Amyotrophic Lateral Sclerosis: An Emerging Era of Collaborative Gene Discovery
2007

Collaborative Gene Discovery in Amyotrophic Lateral Sclerosis

Sample size: 7024 publication Evidence: high

Author Information

Author(s): Gwinn Katrina, Corriveau Roderick A., Mitsumoto Hiroshi, Bednarz Kate, Brown Robert H. Jr., Cudkowicz Merit, Gordon Paul H., Hardy John, Kasarskis Edward J., Kaufmann Petra, Miller Robert, Sorenson Eric, Tandan Rup, Traynor Bryan J., Nash Josefina, Sherman Alex, Mailman Matthew D., Ostell James, Bruijn Lucie, Cwik Valerie, Rich Stephen S., Singleton Andrew, Refolo Larry, Andrews Jaime, Zhang Ran, Conwit Robin, Keller Margaret A.

Primary Institution: National Institute for Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

Hypothesis

Can collaborative efforts in genetic research lead to better understanding and discovery of genes associated with Amyotrophic Lateral Sclerosis (ALS)?

Conclusion

The study established a public repository of DNA and clinical data from thousands of ALS patients and controls to facilitate genetic research.

Supporting Evidence

  • The study discusses a collaboration among 62 centers across the United States to collect biological samples for ALS research.
  • Samples and data from 2332 ALS patients and 4692 controls are publicly available for research.
  • Genome-wide association studies require large sample sizes to identify genetic factors associated with ALS.

Takeaway

Researchers are working together to collect DNA samples from people with ALS and healthy individuals to find out what genes might cause the disease.

Methodology

The study involved collecting DNA and clinical data from ALS patients and controls through a collaboration of various institutions.

Potential Biases

Potential bias in control selection as controls were excluded if they had a family history of neurological disease.

Limitations

The study does not include detailed risk factor information for environmental triggers and relies on a large sample size for statistical power.

Participant Demographics

The sample included 2332 individuals with ALS (49% men, 51% women) and 4692 neurologically normal controls.

Digital Object Identifier (DOI)

10.1371/journal.pone.0001254

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication